Skip to content

Monitoring and Mapping of Erectile Nerve During RALP (MMEN Study)

Safety and Efficacy of Pelvic Autonomic Nerve Monitoring and Mapping During Robot Assisted Laparoscopic Radical Prostatectomy for Preservation of Erectile Function

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02507427
Enrollment
30
Registered
2015-07-24
Start date
2015-07-26
Completion date
2018-03-19
Last updated
2019-02-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Prostate cancer, robot, nerve mapping and monitoring

Brief summary

To evaluate the safety and efficacy of pelvic autonomic nerve monitoring and mapping during robot assisted laparoscopic radical prostatectomy for preservation of erectile function.

Detailed description

Using NIM-Eclipse monitoring instrument (Medtronic), we will check action potential of cavernous nerve, bulbocavernosus reflex and pudendal nerve somatosensory evoked potential in real time during robot assisted laparoscopic radical prostatectomy for preservation of erectile function. In this feasibility and protocol setting phase I/II study, we will evaluate the safety and efficacy of pelvic autonomic nerve monitoring and mapping using NIM-Eclipse monitoring instrument.

Interventions

DEVICENIM-Eclipse

Using NIM-Eclipse, nerve monitoring and mapping are performed

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
19 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* pathologically proven localized prostate cancer (≤cT3a) * patients to undergo robot-assisted laparoscopic prostatectomy at our center

Exclusion criteria

* prior hormone therapy * prior radiation treatment on prostate or pelvis * refused to participate

Design outcomes

Primary

MeasureTime frameDescription
Completion rate of nerve monitoring and mapping during RALPDuring the operationCompletion rate of planed surgery without significant intra-operative complication

Secondary

MeasureTime frameDescription
Adverse event12 monthsRate of adverse events during and after procedures upto 12 months
Quantification of erectile nerve preservationDuring the operationChanges in action potential after prostate removal from the baseline. Electrical stimulation will be given at each neurovascular bundle 3 times. Action potential will be measured at both corpus cavernosum.
Correlation between the quantification and subjective nerve preservation gradeDuring the operationMean value of the quantification by nerve preservation grade (Tewari et al, 2011) which was subjectively scored by the surgeon.
Correlation between the quantification of erectile nerve preservation and the postoperative recovery of erectile function12 monthsRecovery duration of erection measured by the International Index of Erectile Dysfunction(IIEF)-5 score according to the quantification of erectile nerve preservation

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026